stockrow
Friday 6 November 2026
Export PACS’s income statement to Excel — free account
PACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.
- Revenue
- +11.5%
- EPS
- +16.4%
- Free cash flow
- −4.31%
- Total debt
- +7.48%
Quarter to September 2026, against a year earlier
50.09
0.17
−0.34%
Follow PACS
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
31.47 | 20.72 | 25.08 | 23.69 |
P/S ratio |
1.13 | 0.93 | 1.21 | 1.15 | |
P/FCF ratio |
20.01 | 13.22 | 14.77 | 14.67 | |
P/Operating CF |
(1,768.67) | 21.35 | 49.75 | 31.15 | |
P/B ratio |
6.30 | 4.84 | 6.04 | 5.40 | |
Price to Tangible BV |
6.78 | 5.18 | 6.44 | 6.16 | |
EV/Sales |
1.16 | 0.94 | 1.23 | 1.18 | |
EV/EBITDA |
16.69 | 11.42 | 14.17 | 13.46 | |
EV/Operating CF |
15.21 | 10.38 | 11.90 | 11.62 | |
EV/FCF |
20.52 | 13.34 | 14.95 | 15.02 | |
Quick Ratio |
0.90 | 0.91 | 0.84 | 0.73 | |
Current Ratio |
1.07 | 1.00 | 0.91 | 0.80 | |
Net Debt/EBITDA |
1.37 | 0.33 | 0.63 | 1.30 | |
Debt/Assets |
6.25% | 5.18% | 4.35% | 4.60% | |
Debt/Equity |
0.37 | 0.28 | 0.22 | 0.22 | |
Asset Turnover |
0.98 | 0.97 | 0.99 | 0.99 | |
Operating CF/Net income |
(0.06) | 2.93 | 1.77 | 3.47 | |
Capex/Depreciation |
(3.11) | (1.16) | (1.27) | (1.56) | |
Interest Coverage |
11.04 | 18.69 | 18.10 | 19.56 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.36% | 7.91% | 8.00% | 9.24% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.03 | |
Share Based Compensation of Revenue |
1.16% | 1.43% | 1.81% | 3.02% | |
Graham Net Nets |
(0.59) | (0.70) | (0.53) | (0.57) | |
Graham Number |
12.94 | 15.21 | 16.43 | 17.43 | |
Earnings Yield |
3.18% | 4.83% | 3.99% | 4.22% | |
Free Cash Flow Yield |
5.00% | 7.56% | 6.77% | 6.82% | |
Revenue per Share |
8.69 | 9.04 | 9.03 | 9.46 | |
Operating CF per Share |
(0.02) | 1.50 | 0.86 | 1.33 | |
Capex per Share |
(0.32) | (0.14) | (0.17) | (0.21) | |
Free Cash Flow per Share |
(0.34) | 1.37 | 0.69 | 1.13 | |
Cash per Share |
1.26 | 1.58 | 1.04 | 0.73 | |
Shareholders Equity per Share |
6.10 | 6.64 | 7.05 | 7.70 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.10 | 6.64 | 7.05 | 7.70 | |
Free Cash Flow |
(53.75) | 214.51 | 108.98 | 178.74 | |
Working Capital |
68.31 | (5.42) | (92.70) | (235.56) | |
Capital Expenditures |
(50.36) | (21.83) | (26.53) | (32.50) | |
Net Current Asset Value |
(3,561.85) | (3,553.22) | (3,578.57) | (3,752.73) | |
EV/EBIT |
19.86 | 13.34 | 16.63 | 15.90 | |
Capex to Sales |
0.04 | 0.02 | 0.02 | 0.02 | |
Price to Operating Income |
19.37 | 13.23 | 16.43 | 15.53 | |
| Other line items | |||||
Average Receivables |
709.31 | 737.46 | 706.84 | 722.41 | |
Average Payables |
183.65 | 189.64 | 166.45 | 191.38 | |
Average Assets |
5,413.47 | 5,578.96 | 5,579.25 | 5,772.54 | |
Average Common Equity |
834.07 | 899.23 | 964.03 | 1,047.81 |
Columns are period end dates · fundamentals updated 5 Nov 2026